The biotech unicorns are back: Alector burnishes its $1.3B valuation in an IPO that generates $176M in cash
The biotech IPO window is open again, and Alector has taken the leap in style, raising $176 million at a $19 midpoint price and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
